joint venture with novartis
he companies plan to co-develop and co-commercialize a BACE inhibitor program in Alzheimer's Disease (AD); Novartis' oral therapy CNP520 will be the lead molecule
Novartis and Amgen also plan to co-develop and co-commercialize Amgen's migraine portfolio, including fully human monoclonal antibody AMG 334 with first phase III data expected in 2017
Partnership reinforces Novartis' continued commitment to developing and bringing innovative neuroscience treatment options to patients
this company deserves to go bankrupt............it's worthless
This company was created by washington politicioans to downbleand HEU from the russian arsenal.....now that's done they look worthless
I read the 600 patent (7,608,600). Under summary of the invention the word "or" is used multiple times to describe more than one formulation of the drug being patented. As the word or is used to connect words or phrases of equal rank, its use in describing the invention invalidates it because a a specific chemical formulations wasn't identified.
I read the 600 patent (7,608,600). Under summary of the invention the word "or" is used multiple times to describe more than one formulation of the compound being patented. As the word or is used to connect words or phrases of equal rank, its use in describing the invention invalidates the patent because a specific chemical formulations wasn't identified. Its kind of like patenting an alkane with 2-20 carbons in a single chain for use as automobile fuel....octane is gasoline and it has eight carbons
"The study demonstrated that the trial hit its primary endpoint and that treatment with neratinib resulted in a 33% reduction of risk of invasive disease recurrence or death versus placebo."
If someone has breast cancer why are they getting a placebo rather than some type of treatment?
asset sales will pull bacon from fire
VA hubs at LAX and San Francisco mesh well with ALK's Seattle operations. There is substantial route overlap. This deal is accretive with probablly $1B LT Debt added to balance sheet....$250M bet income exchanged for $1B LTD is a good deal.
Through an Exclusive Channel Collaboration agreement, Intrexon received a technology access fee of $10 million. Intrexon T1D Partners, LLC, in which Intrexon owns a fifty percent interest, will be responsible for all costs related to the development, manufacture, approval and commercialization of the product.
the solar revolution is about to go nuclear with uranium coated photo-fission panels.
no difference between juinior mining companies selling the dream of a big gold deposit find or junior biotechs promising to solve the world's ills............
Land based phosphate mining has issues with uranium and radium contained in the phosphate mineral apatite. What was projected gross alpha activity in sea water from dredge plume?